BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 19271374)

  • 1. Treatment of recalcitrant verruca vulgaris with Candida antigen in patient with human immunodeficiency virus.
    Summers P; Richards-Altmon P; Halder R
    J Drugs Dermatol; 2009 Mar; 8(3):268-9. PubMed ID: 19271374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intralesional injection of mumps or Candida skin test antigens: a novel immunotherapy for warts.
    Johnson SM; Roberson PK; Horn TD
    Arch Dermatol; 2001 Apr; 137(4):451-5. PubMed ID: 11295925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uveitis Following Treatment of Verruca Vulgaris with Intralesional
    Crowley NJ; Hagan JC; Dyer JA; Brundige TF
    Mo Med; 2017; 114(5):394-395. PubMed ID: 30228642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intralesional Candida antigen for common warts in people with HIV.
    Wong A; Crawford RI
    J Cutan Med Surg; 2013; 17(5):313-5. PubMed ID: 24067850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Candida albicans intralesional injection immunotherapy of warts.
    Signore RJ
    Cutis; 2002 Sep; 70(3):185-92. PubMed ID: 12353895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of flat warts using intralesional Candida antigen.
    Ritter SE; Meffert J
    Arch Dermatol; 2003 Apr; 139(4):541-2. PubMed ID: 12707109
    [No Abstract]   [Full Text] [Related]  

  • 7. Lymphangitis occurring after intralesional Candida antigen injection for verruca vulgaris.
    Zubritsky L; Alikhan A
    Dermatol Online J; 2016 Jun; 22(6):. PubMed ID: 27617613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regression of Nevi After Candida Injection for the Treatment of Verruca Vulgaris.
    Kollmann E; Cleaver D; Cleaver L; Cleaver J
    Pediatr Dermatol; 2017 Mar; 34(2):199-200. PubMed ID: 27981626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Candida antigen injections for the treatment of verruca vulgaris: A two-year mayo clinic experience.
    Alikhan A; Griffin JR; Newman CC
    J Dermatolog Treat; 2016 Aug; 27(4):355-8. PubMed ID: 26558635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of nongenital cutaneous warts.
    Mulhem E; Pinelis S
    Am Fam Physician; 2011 Aug; 84(3):288-93. PubMed ID: 21842775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intralesional Candida Antigen Immunotherapy for the Treatment of Recalcitrant and Multiple Warts in Children.
    Muñoz Garza FZ; Roé Crespo E; Torres Pradilla M; Aguilera Peirò P; Baltà Cruz S; Hernández Ruiz ME; Baselga Torres E
    Pediatr Dermatol; 2015; 32(6):797-801. PubMed ID: 26584692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intralesional immunotherapy for genital warts.
    King M; Johnson SM; Horn TD
    Arch Dermatol; 2005 Dec; 141(12):1606-7. PubMed ID: 16365274
    [No Abstract]   [Full Text] [Related]  

  • 13. Intralesional immunotherapy of warts with mumps, Candida, and Trichophyton skin test antigens: a single-blinded, randomized, and controlled trial.
    Horn TD; Johnson SM; Helm RM; Roberson PK
    Arch Dermatol; 2005 May; 141(5):589-94. PubMed ID: 15897380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined bivalent human papillomavirus vaccine and Candida antigen versus Candida antigen alone in the treatment of recalcitrant warts.
    Marei A; Nofal A; Alakad R; Abdel-Hady A
    J Cosmet Dermatol; 2020 Mar; 19(3):758-762. PubMed ID: 31328869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intralesional immunotherapy for warts using a combination of skin test antigens: a safe and effective therapy.
    Johnson SM; Horn TD
    J Drugs Dermatol; 2004; 3(3):263-5. PubMed ID: 15176159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Debilitating verruca vulgaris in a patient infected with the human immunodeficiency virus. Dramatic improvement with hyperthermia therapy.
    Kang S; Fitzpatrick TB
    Arch Dermatol; 1994 Mar; 130(3):294-6. PubMed ID: 8129406
    [No Abstract]   [Full Text] [Related]  

  • 17. Phase 1 clinical trial of intralesional injection of Candida antigen for the treatment of warts.
    Kim KH; Horn TD; Pharis J; Kincannon J; Jones R; O'Bryan K; Myers J; Nakagawa M
    Arch Dermatol; 2010 Dec; 146(12):1431-3. PubMed ID: 21173332
    [No Abstract]   [Full Text] [Related]  

  • 18. The painful purple digit: an alarming complication of Candida albicans antigen treatment of recalcitrant warts.
    Perman M; Sterling JB; Gaspari A
    Dermatitis; 2005 Mar; 16(1):38-40. PubMed ID: 15996350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intralesional immunotherapy with Candida antigen for the treatment of molluscum contagiosum in children.
    Enns LL; Evans MS
    Pediatr Dermatol; 2011; 28(3):254-8. PubMed ID: 21615471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intralesional vitamin D3 versus Candida antigen immunotherapy in the treatment of multiple recalcitrant plantar warts: A comparative case-control study.
    Fathy G; Sharara MA; Khafagy AH
    Dermatol Ther; 2019 Sep; 32(5):e12997. PubMed ID: 31225688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.